Apolipoprotein AII Is a Regulator of Very Low Density Lipoprotein Metabolism and Insulin Resistance

This publication has 92 references indexed in Scilit:

• Triglyceride-Rich Lipoproteins Prime Aortic Endothelium for an Enhanced Inflammatory Response to Tumor Necrosis Factor-α
  Circulation Research, 2007
• Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing
  Journal of Clinical Investigation, 2007
• Mechanisms of Insulin Resistance in Humans and Possible Links With Inflammation
  Hypertension, 2005
• Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.
  Journal of Clinical Investigation, 1997
• Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
  Journal of Clinical Investigation, 1994
• Identification and characterization of apolipoprotein(AII-E2-AII) complex in human plasma lipoprotein
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
• Maternal vitamin levels during pregnancies producing infants with neural tube defects
  The Journal of Pediatrics, 1992
• Relationships between fatty acid synthesis and lipid secretion in the isolated perfused rat liver: Effects of hyperthyroidism, glucose and oleate
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
• Distribution of apolipoprotein E between free and A-II complexed forms in very-low- and high-density lipoproteins: functional implications
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
• Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles
  Biochemical and Biophysical Research Communications, 1987